Skip to main content
. 2022 May 3;13:2400. doi: 10.1038/s41467-022-30003-5

Fig. 1. Summary of histologic and genetic alterations in prostate cancer brain metastases.

Fig. 1

a Histology and immunohistochemistry results, b Summary of non-synonymous mutations/Mb. c Relative contribution of mutational signatures from COSMIC. d Summary of genes showing recurrent mutation or fusion (altered in >5 patients) from WES and targeted RNA-seq data. CNA are shown in large blocks, coding alterations in small blocks. Alteration types are colored according to the legend. Samples are grouped by patient and site (primary or metastasis). Source data are provided in Supplementary Tables 4 and 5.